AstraZeneca and Daiichi Sankyo withdrew their filing for datopotamab deruxtecan (Dato-DXd) in nonsquamous non-small cell lung ...

AstraZeneca announces $2 billion investment to create 1,000 new US jobs, adding to previous $1.5 billion commitment. The $3.5 ...

A flashy collaboration between Sanofi, OpenAI and Formation Bio produced its first AI-powered tool, aiming to speed up the ...

No­var­tis will pay $150 mil­lion up­front to Schrödinger, in a pact an­nounced Tues­day to work to­geth­er on sev­er­al ...

GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...

Bay­er re­it­er­at­ed its plans to ride out the gener­ic-dri­ven sales de­cline of its throm­bo­sis drug Xarel­to, as the ...

Trace Neu­ro­science, a start­up spun out of Maze Ther­a­peu­tics’ pipeline, broke cov­er Tues­day morn­ing with $101 ...

Roche is aligning with Flare Therapeutics to work on small molecules for cancer by going after transcription factor targets, ...

Swiss biotech Alentis Therapeutics thinks it can expand the reach of the Claudin family in oncology, and half a dozen new ...

Thermo Fisher is closing a factory in Lexington, MA, and merging operations with a newer facility in Plainville, MA, to ...

Me is closing its therapeutics division and will wind down ongoing clinical trials, the struggling genetic testing company ...

Rapt Therapeutics is officially shelving its mid-stage immunology candidate after a case of liver failure triggered clinical ...